Delivery Order SPE2DB22D1103-SPE2DB25FTGH1

Award Date 3/3/25
Potential Completion Date 3/24/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The firm-fixed-price Delivery Order, valued at $10,577.74, has a period of performance through November 25, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award, valued at $10,955.43, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $10,955.43, is for the delivery of 4565941413 - BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the supply of BOSULIF 100 MG TABLET 120S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The contract, valued at $11,334.07, is for the delivery of the specialty medication BOSULIF 400 MG TABLET 30S. The award is a Firm Fixed Price delivery order contract that runs through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,334.07 firm fixed-price delivery order is for the supply of BOSULIF 400 MG TABLET 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The $4,991.27 firm fixed price delivery order is for the supply of 120 tablets of the prescription drug BOSULIF 100 MG. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the provision of 120 tablets of the medication BOSULIF 100 MG. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with a ceiling value of $10,955.43, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOSULIF 400 MG TABLET 30S, a prescription medication, to support the healthcare needs of government agencies and programs. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, that...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTGH1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,334.07, is a delivery order for the supply of the pharmaceutical product BOSULIF 400 MG TABLET 30S. The award has an ultimate completion date of March 24, 2025 and a firm fixed price pricing type.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a specific delivery order made against that larger IDC contract vehicle.

Generated 6/2/25, 9:43 AM